submit to the journals

Thyroid Cancer Journal Articles, Videos And Insights

Thyroid Cancer:FEATURED Articles

flipper_slider

Thyroid Cancer: Latest Articles

Thyroid Cancer:FEATURED VIDEOS

Editor's choice

touchONCOLOGY meets with Lori J Wirth from Harvard Medical School and Massachusetts General Hospital in Boston, MA to discuss important treatment approaches and advances for thyroid cancer, including investigating lenvatinib and major findings of the SELECT trial, and how the clinical development of new therapies such as LOXO-292 and spartalizumab may contribute to treatment paradigms moving forward. 1. What factors do you consider when selecting which patients should receive treatment for thyroid cancer? (0:11) 2. What treatment is best for cases of locally advanced or metastatic thyroid cancer that are refractory to radioactive iodine? (0:57) 3. What were the major findings of the SELECT trial investigating levantinib in differentiated thyroid cancer? (1:53) 4. What have been the most important advances in thyroid cancer research in the past year? (3:06) 5. What is the rationale for the use of LOXO-292 for the treatment of thyroid cancer? (4:52) 6. What clinical evidence to date supports the use of LOXO-292 in this application? (5:56) 7. Could you tell us a little about spartalizumab and its clinical development in anaplastic thyroid cancer? (6:32) Speaker disclosures: Lori J Wirth has nothing to disclose in relation to this video interview. Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5 2018
UW Health's Dr. David Schneider explains the treatment options for patients with Follicular Thyroid Cancer.

Thyroid Cancer:Latest Videos

Video List based on Category on Node Page

Latest Videos

touchONCOLOGY meets with Lori J Wirth from Harvard Medical School and Massachusetts General Hospital in Boston, MA to discuss important treatment approaches and advances for thyroid cancer, including investigating lenvatinib and major findings of the SELECT trial, and how the clinical...
Dr Lars Bastholt discusses lenvatinib for the treatment of differentiated thyroid cancer. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
ASCO 2015: Matthew Taylor, MD discusses efficacy and safety of lenvatinib for the treatment of patients with 131I-refractory differentiated thyroid cancer with and without prior VEGF-targeted therapy.
UW Health's Dr. David Schneider explains the treatment options for patients with Follicular Thyroid Cancer.
Living With Thyroid Cancer: Thyroid Tumor Marker.
Dr Tahara (National Cancer Center Hospital East, Kashiwa, Japan) talks to ecancertv at ESMO 2014 about the development of a new targeted therapy for the treatment of iodine-refractory thyroid cancer.

LATEST TWEETS

Conference Highlights